These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12438470)

  • 61. Cellular therapy and induced neuronal replacement for Huntington's disease.
    Benraiss A; Goldman SA
    Neurotherapeutics; 2011 Oct; 8(4):577-90. PubMed ID: 21971961
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cortical Myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential.
    Caviness JN; Kurth M
    Mov Disord; 1997 Nov; 12(6):1046-51. PubMed ID: 9399235
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional integration of striatal allografts in a primate model of Huntington's disease.
    Kendall AL; Rayment FD; Torres EM; Baker HF; Ridley RM; Dunnett SB
    Nat Med; 1998 Jun; 4(6):727-9. PubMed ID: 9623985
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.
    Chen CM; Wu YR; Chang KH
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160844
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 66. What did we learn from neural grafts in Huntington disease?
    Bachoud-Lévi AC
    Rev Neurol (Paris); 2022 May; 178(5):441-449. PubMed ID: 35491247
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of an MRI-based protocol for cell implantation in four patients with Huntington's disease.
    Watts C; Donovan T; Gillard JH; Antoun NM; Burnstein R; Menon DK; Carpenter TA; Fryer T; Thomas DG; Pickard JD
    Cell Transplant; 2003; 12(7):697-704. PubMed ID: 14653617
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fetal striatal homotransplantation for Huntington's disease: first two case reports.
    Madrazo I; Franco-Bourland RE; Castrejon H; Cuevas C; Ostrosky-Solis F
    Neurol Res; 1995 Aug; 17(4):312-5. PubMed ID: 7477750
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention.
    Watts C; Dunnett SB
    J Neurosurg; 1998 Aug; 89(2):267-74. PubMed ID: 9688122
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transplantation of human fetal striatum into a rodent model of Huntington's disease ameliorates locomotor deficits.
    Pundt LL; Kondoh T; Conrad JA; Low WC
    Neurosci Res; 1996 Mar; 24(4):415-20. PubMed ID: 8861112
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Connectivity-based segmentation of the striatum in Huntington's disease: vulnerability of motor pathways.
    Bohanna I; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2011 Jun; 42(3):475-81. PubMed ID: 21382492
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease.
    Brundin P; Fricker RA; Nakao N
    Neuroscience; 1996 Apr; 71(3):895-97. PubMed ID: 8867057
    [No Abstract]   [Full Text] [Related]  

  • 73. From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies.
    Bachoud-Lévi AC
    Prog Brain Res; 2017; 230():227-261. PubMed ID: 28552231
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
    Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
    Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
    Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
    Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Striatal degeneration impairs language learning: evidence from Huntington's disease.
    De Diego-Balaguer R; Couette M; Dolbeau G; Dürr A; Youssov K; Bachoud-Lévi AC
    Brain; 2008 Nov; 131(Pt 11):2870-81. PubMed ID: 18842608
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.
    Handley RR; Reid SJ; Brauning R; Maclean P; Mears ER; Fourie I; Patassini S; Cooper GJS; Rudiger SR; McLaughlan CJ; Verma PJ; Gusella JF; MacDonald ME; Waldvogel HJ; Bawden CS; Faull RLM; Snell RG
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11293-E11302. PubMed ID: 29229845
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
    Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
    Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease.
    Dogan I; Eickhoff CR; Fox PT; Laird AR; Schulz JB; Eickhoff SB; Reetz K
    Neuroimage Clin; 2015; 7():640-52. PubMed ID: 25844318
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Exp Neurol; 2008 Sep; 213(1):137-44. PubMed ID: 18588876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.